Sionna Therapeutics Files Q1 2025 10-Q
Ticker: SION · Form: 10-Q · Filed: May 12, 2025 · CIK: 2036042
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Sionna Therapeutics filed its Q1 2025 10-Q, detailing financials and stock info.
AI Summary
Sionna Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, located at 21 Hickory Drive, Suite 500, Waltham, MA, operates in the Pharmaceutical Preparations sector. Key financial data and stock information for various preferred stock series are detailed within the filing.
Why It Matters
This filing provides investors and analysts with an update on Sionna Therapeutics' financial position and operational details for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Numbers
- 0002036042 — Central Index Key (Unique identifier for Sionna Therapeutics, Inc.)
- 2025-03-31 — Report End Date (End of the reporting period for the 10-Q)
- 2025-05-12 — Filing Date (Date the 10-Q was filed with the SEC)
Key Players & Entities
- Sionna Therapeutics, Inc. (company) — Filer of the 10-Q report
- 21 Hickory Drive, Suite 500, Waltham, MA (location) — Business and mailing address
- 20250331 (date) — Conformed period of report
FAQ
What is the primary business of Sionna Therapeutics, Inc.?
Sionna Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
What is the fiscal year end for Sionna Therapeutics, Inc.?
The fiscal year end for Sionna Therapeutics, Inc. is December 31 (1231).
What is the SEC file number for Sionna Therapeutics, Inc.?
The SEC file number for Sionna Therapeutics, Inc. is 001-42504.
What is the business phone number for Sionna Therapeutics, Inc.?
The business phone number for Sionna Therapeutics, Inc. is 617-819-2020.
What are the different series of convertible preferred stock mentioned in the filing?
The filing mentions Series Seed Convertible Preferred Stock, Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, and Series C Convertible Preferred Stock.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Sionna Therapeutics, Inc. (SION).